loadpatents
name:-0.046181201934814
name:-0.031033039093018
name:-0.010056018829346
Wang; Yuguang Patent Filings

Wang; Yuguang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Yuguang.The latest application filed is for "small-molecule inhibitor of pd-1/pd-l1, pharmaceutical composition thereof with pd-l1 antibody, and application of same".

Company Profile
4.28.37
  • Wang; Yuguang - Guangzhou CN
  • Wang; Yuguang - Shanghai CN
  • Wang; Yuguang - Cambridge MA
  • Wang; Yuguang - Guangdong CN
  • Wang; Yuguang - Monroe NJ
  • Wang; Yuguang - North Brunswick NJ
  • Wang; Yuguang - Mesa AZ
  • Wang; Yuguang - East Brunswick NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
Grant 11,384,048 - Wang , et al. July 12, 2
2022-07-12
Salt of fused ring pyrimidine compound, crystal form thereof and preparation method therefor and use thereof
Grant 11,352,368 - Wang , et al. June 7, 2
2022-06-07
Small-molecule Inhibitor Of Pd-1/pd-l1, Pharmaceutical Composition Thereof With Pd-l1 Antibody, And Application Of Same
App 20220168268 - Wang; Yuguang ;   et al.
2022-06-02
Processes and intermediates for the preparation of soluble guanylate cyclase stimulators
Grant 11,274,096 - Wallace , et al. March 15, 2
2022-03-15
Novel Processes And Intermediates For The Preparation Of Soluble Guanylate Cyclase Stimulators
App 20220024909 - Wallace; Debra Jane ;   et al.
2022-01-27
Diphenyl-like Compound, Intermediate Thereof, Preparation Method Therefor, Pharmaceutical Composition Thereof And Uses Thereof
App 20210387941 - WANG; Yuguang ;   et al.
2021-12-16
Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
Grant 11,078,192 - Wang , et al. August 3, 2
2021-08-03
Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharmaceutical composition and application thereof
Grant 11,066,413 - Wang , et al. July 20, 2
2021-07-20
Salt Of Fused Ring Pyrimidine Compound, Crystal Form Thereof And Preparation Method Therefor And Use Thereof
App 20210198275 - WANG; Yuguang ;   et al.
2021-07-01
Aromatic Vinyl Or Aromatic Ethyl Derivative, Preparation Method Therefor, Intermediate, Pharmaceutical Composition, And Application
App 20210061755 - WANG; Yuguang ;   et al.
2021-03-04
Novel Processes And Intermediates For The Preparation Of Soluble Guanylate Cyclase Stimulators
App 20210053962 - Wallace; Debra Jane ;   et al.
2021-02-25
Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof
Grant 10,611,770 - Zhang , et al.
2020-04-07
Aminopyrimidine Five-membered Heterocyclic Compound, And Intermediate, Preparation Method, Pharmaceutical Composition And Applic
App 20200048270 - WANG; Yuguang ;   et al.
2020-02-13
Fused ring pyrimidine compound, intermediate, and preparation method, composition and use thereof
Grant 10,494,378 - Xu , et al. De
2019-12-03
Aromatic Acetylene Or Aromatic Ethylene Compound, Intermediate, Preparation Method, Pharmaceutical Composition And Use Thereof
App 20190308957 - WANG; Yuguang ;   et al.
2019-10-10
Condensed-ring Pyrimidylamino Derivative, Preparation Method Therefor, And Intermediate, Pharmaceutical Composition And Applicat
App 20190177332 - ZHANG; Nong ;   et al.
2019-06-13
Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof
Grant 10,259,816 - Zhang , et al.
2019-04-16
Fused Ring Pyrimidine Compound, Intermediate, And Preparation Method, Composition And Use Thereof
App 20180208604 - XU; Zusheng ;   et al.
2018-07-26
Condensed-ring Pyrimidylamino Derivative, Preparation Method Therefor, And Intermediate, Pharmaceutical Composition And Applications Thereof
App 20180127420 - ZHANG; Nong ;   et al.
2018-05-10
Mineralocorticoid receptor antagonists
Grant 9,487,506 - Lan , et al. November 8, 2
2016-11-08
Mineralocorticoid receptor antagonists
Grant 9,403,807 - Crespo , et al. August 2, 2
2016-08-02
Mineralocorticoid Receptor Antagonists
App 20150284376 - Crespo; Alejandro ;   et al.
2015-10-08
Mineralocorticoid receptor antagonists
Grant 8,933,113 - Crespo , et al. January 13, 2
2015-01-13
Mineralocorticoid Receptor Antagonists
App 20140336224 - Lan; Ping ;   et al.
2014-11-13
Mineralocorticoid Receptor Antagonists
App 20130331419 - Crespo; Alejandro ;   et al.
2013-12-12
Inhibitors Of Akt Activity
App 20130102605 - Liang; Peng ;   et al.
2013-04-25
Bicyclic And Tricyclic Derivatives As Thrombin Receptor Antagonists
App 20120157403 - Chackalamannil; Samuel ;   et al.
2012-06-21
Bicyclic and tricyclic derivatives as thrombin receptor antagonists
Grant 8,153,664 - Chackalamannil , et al. April 10, 2
2012-04-10
Cannabinoid receptor modulators
Grant 7,897,601 - Chackalamannil , et al. March 1, 2
2011-03-01
Oxazoloisoquinoline derivatives as thrombin receptor antagonists
Grant 7,888,369 - Chackalamannil , et al. February 15, 2
2011-02-15
Thrombin receptor antagonists
Grant 7,713,999 - Chackalamannil , et al. May 11, 2
2010-05-11
Xanthine phosphodiesterase V inhibitors
Grant 7,531,544 - Chackalamannil , et al. May 12, 2
2009-05-12
Constrained himbacine analogs as thrombin receptor antagonists
Grant 7,442,712 - Chelliah , et al. October 28, 2
2008-10-28
Bicyclic And Tricyclic Derivatives As Thrombin Receptor Antagonists
App 20080090830 - Chackalamannil; Samuel ;   et al.
2008-04-17
Thrombin Receptor Antagonists Based On The Modified Tricyclic Unit Of Himbacine
App 20080085923 - Chackalamannil; Samuel ;   et al.
2008-04-10
Xanthine Phosphodiesterase V Inhibitors
App 20080058354 - Chackalamannil; Samuel ;   et al.
2008-03-06
Thrombin receptor antagonists
Grant 7,304,078 - Chackalamannil , et al. December 4, 2
2007-12-04
Thrombin Receptor Antagonists
App 20070270439 - Chackalamannil; Samuel ;   et al.
2007-11-22
Cannabinoid Receptor Modulators
App 20070254952 - Wang; Yuguang ;   et al.
2007-11-01
Xanthine phosphodiesterase V inhibitors
Grant 7,268,141 - Chackalamannil , et al. September 11, 2
2007-09-11
Cannabinoid receptor modulators
App 20070197628 - Chackalamannil; Samuel ;   et al.
2007-08-23
Thrombin Receptor Antagonists
App 20070179187 - Chackalamannil; Samuel ;   et al.
2007-08-02
Oxazoloisoquinoline derivatives as thrombin receptor antagonists
App 20070149518 - Chackalamannil; Samuel ;   et al.
2007-06-28
Computer finger mouse
App 20060007152 - Wang; Yuguang
2006-01-12
Constrained himbacine analogs as thrombin receptor antagonists
App 20050267155 - Chelliah, Mariappan V. ;   et al.
2005-12-01
Polycyclic guanine phosphodiesterase V inhibitors
Grant 6,969,719 - Asberom , et al. November 29, 2
2005-11-29
Finger mouse
Grant D509,828 - Wang September 20, 2
2005-09-20
Xanthine phosphodiesterase V inhibitors
App 20050182077 - Chackalamannil, Samuel ;   et al.
2005-08-18
Xanthine phosphodiesterase V inhibitors
App 20050075349 - Chackalamannil, Samuel ;   et al.
2005-04-07
Muscarinic antagonists
Grant 6,831,089 - Wang , et al. December 14, 2
2004-12-14
Xanthine phosphodiesterase V inhibitors
Grant 6,821,978 - Chackalamannil , et al. November 23, 2
2004-11-23
Xanthine phosphodiesterase V inhibitors
App 20040229885 - Chackalamannil, Samuel ;   et al.
2004-11-18
Xanthine phosphodiesterase V inhibitors
App 20040167137 - Chackalamannil, Samuel ;   et al.
2004-08-26
Thrombin receptor antagonists
App 20030216437 - Chackalamannil, Samuel ;   et al.
2003-11-20
Muscarinic antagonists
App 20030207917 - Wang, Yuguang ;   et al.
2003-11-06
Polycyclic guanine phosphodiesterase V inhibitors
App 20030153587 - Asberom, Theodros ;   et al.
2003-08-14
Xanthine phosphodiesterase V inhibitors
App 20020169174 - Chackalamannil, Samuel ;   et al.
2002-11-14
Muscarinic antagonists
Grant 6,043,255 - Lowe , et al. March 28, 2
2000-03-28
Ether muscarinic antagonists
Grant 5,977,138 - Wang , et al. November 2, 1
1999-11-02
Muscarinic antagonists
Grant 5,889,006 - Lowe , et al. March 30, 1
1999-03-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed